4 results
IgM and Non-IgM - Risk and Type of Progression #EBM #Honc #MGUS #Progression #IgM #NonIgM #MultipleMyeloma
IgM and Non-IgM ... of Progression #EBM ... #Honc #MGUS #Progression ... #IgM #NonIgM #MultipleMyeloma ... #NEJM
Cumulative Incidence of Progression of MGUS, with Death Accounted for as a Competing Risk #EBM #Honc
Progression of MGUS ... Competing Risk #EBM ... #Honc #MGUS #Progression ... #IgG #MGUS #NEJM
Event Rates of the Primary End Point and Its Components at 30 Days #EBM #Cardiology #CULPRIT-SHOCK
Components at 30 Days #EBM ... #Cardiology #CULPRIT-SHOCK ... #CulpritOnly #shock ... #cardiogenic #NEJM
PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock - Event Rates of the
and Cardiogenic Shock ... #EBM #Cardiology ... #CULPRIT-SHOCK ... #CulpritOnly #shock ... #cardiogenic #NEJM